July 29, 2014 3:29 PM ET

Biotechnology

Company Overview of Cerulean Pharma Inc.

Executive Profile

David P. DeMagistris Ph.D.

Senior Vice President of Pharmaceutical Sciences, Cerulean Pharma Inc.
AgeTotal Calculated CompensationThis person is connected to 0 Board Members in 0 different organizations across 1 different industries.

----

Background

David P. DeMagistris, Ph.D has been Senior Vice President of Pharmaceutical Sciences of Cerulean Pharma Inc. since October, 2008. Dr. DeMagistris has more than 25 years of experience in pharmaceutical development and drug delivery. Prior to joining Cerulean, he led Strategic Technology at GlaxoSmithKline, a global organization charged with inventing and incubating novel technologies useful in delivering both clinical and commercial drug products. He has served a variety ...

Corporate Headquarters

840 Memorial Drive
Cambridge, Massachusetts 02139

United States

Phone: 617-551-9600
Fax: 617-494-1544

Board Members Memberships

There is no Board Members Memberships data available.

Education

There is no Education data available.

Other Affiliations

There is no Company Affiliations data available.

Annual Compensation

There is no Annual Compensation data available.

Stocks Options

There is no Stock Options data available.

Total Compensation

There is no Total Compensation data available.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

COMPETITOR COMPENSATION

There is no Competitor Compensation data available.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Cerulean Pharma Inc., please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.